Abstracts

CD169 Mediates HIV-1 Evasion from Detection by α-gp120 Neutralizing Antibodies in Dendritic Cells

Background: A hallmark of chronic HIV-1 infection is constitutive immune activation associated with elevated serum levels of proinflammatory cytokines, mainly induced by microbial translocation across the gut mucosa. We have previously demonstrated that dendritic cells (DCs) matured in the presence of IFNα or LPS, up-regulate a myeloid cell-specific receptor CD169 or Siglec1, the predominant DC…

Type I Interferon Signaling Is Critical for Early Control of Immune System Damage

Background: Whether type I IFN (IFN-I) is beneficial in HIV infection by inducing antiviral genes or detrimental by driving immune activation is controversial. IFN receptor antagonist (IFN-1ant) treatment during acute SIV infection accelerated progression to AIDS and death. Its mechanism and the consequences of exogenous IFN-I treatment during acute infection are unknown. Methodology: 6 rhesus…

miR-422a: A Solitary MicroRNA Biomarker of Interferon-α Anti-HIV-1 Activity In Vivo

Background: The cytokine interferon-α (IFN-α) potently suppresses HIV-1 in vitro and in vivo. IFN-α therapy was also recently associated with significant reduction in the size of the HIV-1 latent reservoir. We hypothesized that microRNAs (miRNAs) contribute to the IFN-α-mediated suppression of HIV-1. To inform the development of novel miRNA-based antiretroviral strategies, we investigated the effects…

HIV-1 Evades Innate Immune Recognition Through Specific Co-Factor Recruitment

Background: HIV-1 is able to replicate in primary human macrophages without stimulating innate immune sensors despite reverse transcription of genomic RNA into double stranded DNA in the infected cell cytoplasm, an activity that might be expected to trigger innate pattern recognition receptors (PRRs). We hypothesized that if correctly orchestrated HIV-1 uncoating and nuclear entry is…

Interferon Treatments for Chronic Hepatitis C

Background: Chronic hepatitis caused by infection with hepatitis C virus C (chronic hepatitis C (CHC)) is a leading cause of liver disease worldwide. For the past 25 years, recombinant interferon-α (IFNα) has been the main component of treatments for HCV infection. IFNα binds to its cognate cell surface receptor (IFNAR) and activates the Jak-STAT pathway,…

Perturbing Interferon Signaling in SIV Infection

Background: Two studies will be presented which describe the consequences of type I interferon receptor blockade and interferon alpha administration in rhesus macaques during SIV challenge and acute infection. Conclusions: Emphasis will be on analysis of interferon stimulated gene expression innate immunity virus replication CD4 T cell depletion and clinical outcome

Type 1 Interferon-Mediated Selective Pressure on HIV-1 Transmission

Background: Understanding host mechanisms of immune control of HIV-1 replication during the earliest stages of infection prior to systemic virus dissemination constitutes a key first step in the rational development of novel strategies to limit virus transmission. Production of type 1 interferons (IFNs), pleiotropic innate cytokines that mediate direct antiviral activity and exert a multitude…